I N N O V A T I O N S
I N C L I N I C A L
N E U R O S C I E N C E
The official journal of
I S C D D
The international Society
for CNS Drug Development
I C N S
VOL. 14, NO. 11–12 • NOVEMBER-DECEMBER 2017
PEER-REVIEWED • EVIDENCE-BASED • INDEXED ON PUBMED CENTRAL
THE POSITIVE AND NEGATIVE SYNDROME SCALE
(PANSS)—Past, Present, and Future Developments:
A Compendium of Research and Perspectives
INSIDE THE ISSUE:
• PRECURSORS TO THE PANSS: The BPRS and its Progenitors
• A DEVELOPMENTAL HISTORY of the Positive and Negative Syndrome Scale
(PANSS)
• USING THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) to Define
Different Domains of Negative Symptoms: Prediction of Everyday Functioning by
Impairments in Emotional Expression and Emotional Experience
• INSIGHT AND TREATMENT OUTCOMES IN SCHIZOPHRENIA: Post-hoc
Analysis of a Long-term, Double-blind Study Comparing Lurasidone and
Quetiapine XR
• NEGATIVE SYMPTOM DIMENSIONS of the Positive and Negative Syndrome
Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural
Consistency
• DISPARITY BETWEEN GENERAL SYMPTOM RELIEF AND REMISSION CRITERIA
in the Positive and Negative Syndrome Scale (PANSS): A Post-treatment Bifactor
Item Response Theory Model
• UNDERSTANDING ANTIPSYCHOTIC DRUG TREATMENT EFFECTS: A Novel
Method to Reduce Pseudospecificity of PANSS Factors
• SENSITIVIT Y OF THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS)
in Detecting Treatment Effects via Network Analysis
• BRIDGING THE MEASUREMENT GAP Between Research and Clinical Care in
Schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and Other
Assessments Based on the Simplified Negative and Positive Symptoms Interview
(SNAPSI)
• ARE SHORTER VERSIONS of the Positive and Negative Syndrome Scale (PANSS)
Doable? A Critical Review
• POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS)TRAINING: Challenges,
Solutions, and Future Directions
Follow us.
INNOVATIONSCNS.COM
PANSS
3 0
t h
A n n i v e r s a r y
S p e c i a l E d i t i o n
3 0
t h
A n n i v e r s a r y
S p e c i a l E d i t i o n